Gill Karen M, Mishel Merle, Belyea Michael, Germino Barbara, Germino Laura S, Porter Laura, LaNey Iris Carlton, Stewart Janet
School of Nursing, University of North Carolina, Chapel Hill, NC, USA.
Oncol Nurs Forum. 2004 May;31(3):633-9. doi: 10.1188/04.onf.633-639.
PURPOSE/OBJECTIVES: To examine the sources of uncertainty in older African American and Caucasian long-term breast cancer survivors by focusing on frequency of triggers of uncertainty about cancer recurrence and physical symptoms linked to long-term treatment side effects.
In the context of a larger randomized, controlled treatment-outcome study, data were gathered from 10 monthly follow-up telephone calls by nurses.
Rural and urban regions of North Carolina.
244 older women (mean age = 64 years); 73 African American women and 171 Caucasian women who were five to nine years after breast cancer diagnosis.
The most frequent triggers were hearing about someone else's cancer and new aches and pains. The most frequent symptoms were fatigue, joint stiffness, and pain. Although no ethnic differences occurred in the experience of symptoms, Caucasian women were more likely than African American women to report that their fears of recurrence were triggered by hearing about someone else's cancer, environmental triggers, and information or controversy about breast cancer discussed in the media.
Illness uncertainty persisted long after cancer diagnosis and treatment, with most women experiencing multiple triggers of uncertainty about recurrence and a range of symptoms and treatment side effects.
Nurses can help cancer survivors to identify, monitor, and manage illness uncertainty and emotional distress.
目的/目标:通过关注癌症复发不确定性的触发频率以及与长期治疗副作用相关的身体症状,研究老年非裔美国人和白人乳腺癌长期幸存者不确定性的来源。
在一项更大规模的随机对照治疗结果研究中,护士通过10次每月随访电话收集数据。
北卡罗来纳州的农村和城市地区。
244名老年女性(平均年龄 = 64岁);73名非裔美国女性和171名白人女性,她们在乳腺癌诊断后5至9年。
最常见的触发因素是听说其他人患癌以及新出现的疼痛。最常见的症状是疲劳、关节僵硬和疼痛。尽管在症状体验方面没有种族差异,但白人女性比非裔美国女性更有可能报告,她们对复发的恐惧是由听说其他人患癌、环境触发因素以及媒体上讨论的乳腺癌信息或争议引发的。
癌症诊断和治疗后很长时间,疾病不确定性依然存在,大多数女性经历了多次复发不确定性的触发因素以及一系列症状和治疗副作用。
护士可以帮助癌症幸存者识别、监测和管理疾病不确定性及情绪困扰。